Colleen Lewis was named vice president of nursing and research at Florida Cancer Specialists and Research Institute, LLC.
Justin F. Klamerus was named executive vice president and chief medical officer at McLaren Health Care.
Jeffrey M. Rosen will receive the William L. McGuire Memorial Lecture Award at the 2022 San Antonio Breast Cancer Symposium, to be held Dec. 6-10, 2022.
The American Society for Radiation Oncology selected 27 members to receive the ASTRO Fellow designation. The 2022 class will be recognized at an awards ceremony in San Antonio Oct. 25, during ASTRO’s 64th annual meeting.
The Association of Community Cancer Centers released the following statement in response to a new payment model proposed by the Centers for Medicare and Medicaid Services.
Researchers at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute identified key features of a gene mutation responsible for 15-20% of all melanomas.
The SWOG Cancer Research Network has partnered with cloud clinical research software company nCoup to pilot and deploy the company’s nCartes platform at SWOG sites to help advance data collection.
FDA approved Breyanzi (lisocabtagene maraleucel), a CD19-directed CAR T-cell therapy, for the treatment of adult patients with large B-cell lymphoma
The European Medicines Agency’s Committee for Medicinal Products for Human Use adopted a positive opinion recommending approval of Lynparza (olaparib) for the adjuvant treatment of patients with germline BRCA-mutated, HER2-negative high-risk early breast cancer who have been treated with neoadjuvant or adjuvant chemotherapy.
Indianapolis-based Community Health Network and GRAIL LLC have partnered to offer Galleri, GRAIL’s multi-cancer early detection blood test, to individuals at Community Health Network’s sites of care.
